Respiratory News and Research

RSS

Flour and cleaning products cause occupational asthma in France

Flour has been identified as the main cause of occupational asthma in France, closely followed by cleaning products.

8 Sep 2014

Eating food just before taking TB drug could reduce effectiveness of medicine

The timing of food intake in the early phase of TB treatment could have a negative impact on the effectiveness of TB treatment.

8 Sep 2014

Higher pollution levels linked to deteriorating lung health among adult European citizens

New data has identified a clear link between higher levels of exposure to air pollution and deteriorating lung health in adult European citizens. This study confirms previous findings that children growing up in areas with higher levels of pollution will have lower levels of lung function and a higher risk of developing symptoms such as cough and bronchitis symptoms.

6 Sep 2014

Avian influenza A H3N8 virus poses threat to humans

A study led by St. Jude Children's Research Hospital scientists found the avian influenza A H3N8 virus that killed harbor seals along the New England coast can spread through respiratory droplets and poses a threat to humans.

5 Sep 2014

Sepsis patients more likely to survive when treated at hospital with higher volume of cases

Patients with sepsis, one of the most time-sensitive and hard-to-detect illnesses in medicine, are more likely to survive the life-threatening condition when treated at a hospital that sees a higher volume of sepsis cases.

4 Sep 2014

3 billion people worldwide at risk of early death due to household air pollution

Household air pollution, caused by the use of plant-based or coal fuel for cooking, heating, and lighting, is putting nearly three billion people worldwide at risk of ill health and early death, according to a new Commission, published in The Lancet Respiratory Medicine journal.

4 Sep 2014

Accreditation of bariatric surgery centers contributes to improved safety for patients

Patients who underwent weight loss operations in recent years, when most bariatric surgical centers were accredited, had fewer postoperative complications and were 2.3 times less likely to die in the hospital than patients who had bariatric procedures performed before a national movement toward facility accreditation was taking place, according to new study findings.

4 Sep 2014

Exposure to certain phenols during pregnancy may disrupt growth of boys

A research consortium bringing together teams from Inserm, the Nancy and Poitiers University Hospitals, and the Centers for Disease Control and Prevention (CDC, Atlanta, USA), and coordinated by the Inserm and University of Grenoble Environmental Epidemiology team (Unit 823), has just published an epidemiological study indicating that exposure to certain phenols during pregnancy, especially parabens and triclosan, may disrupt growth of boys during foetal growth and the first years of life.

4 Sep 2014

Ludwig, CRI collaborate with VentiRx to conduct clinical trial with motolimod and immunotherapy agents

The nonprofits Ludwig Cancer Research (Ludwig) and the Cancer Research Institute (CRI) announced today an agreement with VentiRx Pharmaceuticals Inc., a clinical stage biopharmaceutical company, to conduct a clinical trial with motolimod (VTX-2337) combined with other immunotherapy agents available to Ludwig and CRI through other industry partnerships.

4 Sep 2014

CAT score useful for predicting COPD exacerbations

The likelihood and imminence of a chronic obstructive pulmonary disease exacerbation in high-risk patients could be predicted using the COPD assessment test score, study findings indicate.

3 Sep 2014

Type 2 diabetes adds to hospital mortality risk in bipolar patients

Type 2 diabetes is a major contributor to mortality in patients with bipolar disorder who are admitted to general hospitals, a study shows.

3 Sep 2014

Distinct features of COPD–asthma overlap syndrome identified

US researchers have shown that patients with both chronic obstructive pulmonary disease and asthma have more exacerbations, less emphysema and more airway disease than patients with COPD alone.

3 Sep 2014

Researchers identify different types of tuberculosis using new genetic barcode

Doctors and researchers will be able to easily identify different types of tuberculosis (TB) thanks to a new genetic barcode devised by scientists from the London School of Hygiene & Tropical Medicine.

3 Sep 2014

Researchers discover pattern of infection of bacterium responsible for causing severe lung infections

Researchers at the University of Liverpool's Institute of Infection and Global Health have discovered the pattern of infection of the bacterium responsible for causing severe lung infections in people with cystic fibrosis.

3 Sep 2014

White pill may help scientists learn why patients with cystic fibrosis have less exercise capacity

A little white pill may help scientists learn why patients with cystic fibrosis have less exercise capacity than their peers, even if their lungs are relatively healthy.

3 Sep 2014

BreathingSpace health facility improves quality of life for people with severe respiratory disease

A unique national health pilot supported by the Coalfields Regeneration Trust, has provided a radical step change in improving the quality of life for people in Rotherham with severe respiratory disease, with reported deaths from bronchiectasis and Chronic Obstructive Pulmonary Disease (COPD) now 30% lower than the national average just 6 years after its opening.

3 Sep 2014

VentiRx's motolimod receives FDA Fast Track designation for ovarian cancer treatment

VentiRx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company committed to the development and commercialization of novel Toll-like receptor 8 (TLR8) immunotherapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the investigation of motolimod (VTX-2337) when administered in combination with pegylated liposomal doxorubicin (PLD) for the treatment of women with ovarian cancer whose disease has progressed on or recurred after platinum-based chemotherapy.

2 Sep 2014

Soligenix announces promising preliminary results from study on ricin toxin vaccine

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today promising preliminary results from a preclinical study with its ricin toxin vaccine RiVax™, in a non-human primate (NHP) lethal aerosol exposure model.

2 Sep 2014

Cepheid releases Xpert Flu/RSV XC for accurate determination of Flu A, Flu B and RSV infection

Cepheid announced today the release of Xpert® Flu/RSV XC, an on-demand molecular test for rapid, accurate and reliable determination of Flu A, Flu B, and differentiation of RSV infection.

2 Sep 2014

New genetic barcode helps identify different types of tuberculosis

2 Sep 2014

Respiratory News and Research

Flour and cleaning products cause occupational asthma in France

Eating food just before taking TB drug could reduce effectiveness of medicine

Higher pollution levels linked to deteriorating lung health among adult European citizens

Avian influenza A H3N8 virus poses threat to humans

Sepsis patients more likely to survive when treated at hospital with higher volume of cases

3 billion people worldwide at risk of early death due to household air pollution

Accreditation of bariatric surgery centers contributes to improved safety for patients

Exposure to certain phenols during pregnancy may disrupt growth of boys

Ludwig, CRI collaborate with VentiRx to conduct clinical trial with motolimod and immunotherapy agents

CAT score useful for predicting COPD exacerbations

Type 2 diabetes adds to hospital mortality risk in bipolar patients

Distinct features of COPD–asthma overlap syndrome identified

Researchers identify different types of tuberculosis using new genetic barcode

Researchers discover pattern of infection of bacterium responsible for causing severe lung infections

White pill may help scientists learn why patients with cystic fibrosis have less exercise capacity

BreathingSpace health facility improves quality of life for people with severe respiratory disease

VentiRx's motolimod receives FDA Fast Track designation for ovarian cancer treatment

Soligenix announces promising preliminary results from study on ricin toxin vaccine

Cepheid releases Xpert Flu/RSV XC for accurate determination of Flu A, Flu B and RSV infection

New genetic barcode helps identify different types of tuberculosis

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News